Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Single-blinded, Randomized, Controlled, Comparative Phase III Study of EVARREST Fibrin Sealant Patch in Cardiovascular Surgery
2013-003464-31Phase 3Completed
- Sponsor
- Ethicon
- Start
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fibrin Pad in Cardiovascular surgical bleeding (CSB) (2 arms), sponsored by Ethicon. Primary endpoint: Primary hemostasis endpoint. Started Nov 2013; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
Cardiovascular surgical bleeding (CSB)
Beyond the preview
Go deeper on 2013-003464-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003464-31.